Details for Patent: 10,238,662
✉ Email this page to a colleague
Which drugs does patent 10,238,662 protect, and when does it expire?
Patent 10,238,662 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.
This patent has seven patent family members in four countries.
Summary for Patent: 10,238,662
| Title: | Needle assisted jet injection administration of testosterone compositions |
| Abstract: | The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device. |
| Inventor(s): | Wotton; Paul K. (Newtown, PA), Jooste; Hermanus L. (Wayne, PA), Dave; Kaushik J. (Edison, NJ), Jaffe; Jon (Annandale, NJ) |
| Assignee: | ANTARES PHARMA, INC. (Ewing, NJ) |
| Application Number: | 15/119,344 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,238,662
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | 10,238,662 | ⤷ Subscribe | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | 10,238,662 | ⤷ Subscribe | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | 10,238,662 | ⤷ Subscribe | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,238,662
| PCT Information | |||
| PCT Filed | February 19, 2015 | PCT Application Number: | PCT/US2015/016505 |
| PCT Publication Date: | August 27, 2015 | PCT Publication Number: | WO2015/127012 |
International Family Members for US Patent 10,238,662
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2939791 | ⤷ Subscribe | |||
| European Patent Office | 3107547 | ⤷ Subscribe | |||
| European Patent Office | 4062918 | ⤷ Subscribe | |||
| Japan | 2017513809 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
